The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
Open accessAbstract
Pathophysiological, epidemiologic and genetic studies provide strong evidence that Lp(a) is a causal mediator of cardiovascular disease (CVD) and calcific aortic valve disease (CAVD). Specific therapies to address Lp(a)-mediated CVD and CAVD are in clinical development. Due to knowledge gaps, the National Heart, Lung, and Blood Institute (NHLBI) organized a Working Group (WG) that identified challenges in fully understanding the role of Lp(a) in CVD/CAVD. These included the lack of research funding, inadequate experimental models, lack of globally standardized Lp(a) assays and inadequate understanding of the mechanisms underlying current drug therapies on Lp(a) levels. Specific recommendations were provided to facilitate basic, mechanistic, preclinical, and clinical research on Lp(a), foster collaborative research and resource sharing, leverage expertise of different groups and centers with complementary skills, and utilize existing NHLBI resources. Concerted efforts to understand Lp(a) pathophysiology, together with diagnostic and therapeutic advances, are required to reduce Lp(a)-mediated risk of CVD and CAVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw272 · Cited by 3,162
Lipoprotein(a) as a cardiovascular risk factor: current status
Nordestgaard, B. G., Chapman, M. J., Ray, K., Borén, J., Andreotti, F., Watts, G. F., Ginsberg, H., Amarenco, P., Catapano, A., Descamps, O. S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq386 · Cited by 1,807
Self-citation(2009) · JAMA · doi:10.1001/jama.2009.1063 · Cited by 1,753
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Kamstrup, P. R. (2009) · JAMA · doi:10.1001/jama.2009.801 · Cited by 1,357 · cited 1×
“Data from subjects without prior CVD suggest the threshold for elevated CVD risk is >20 to 25 mg/dl or >50 to 75 nmol/l (13,14,42) but levels in subjects with prior CVD may be >40 to 50 mg/dl (1).”
BackgroundAnderson, T. J., Grégoire, J., Pearson, G. J., Barry, A. R., Couture, P., Dawes, M., Francis, G. A., Genest, J., Grover, S., Gupta, M., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.510 · Cited by 1,173
Self-citationA Test in Context: Lipoprotein(a)
Tsimikas, S. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.11.042 · Cited by 1,137
Self-citationGenetic Associations with Valvular Calcification and Aortic Stenosis
Thanassoulis, G., Campbell, C. Y., Owens, D. S., Smith, J. G., Smith, A. V., Peloso, G. M., Kerr, K. F., Pechlivanis, S., Budoff, M. J., Harris, T. B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1109034 · Cited by 1,008
Self-citationViney, N. J., van Capelleveen, J. C., Geary, R. S., Xia, S., Tami, J. A., Yu, R. Z., Marcovina, S. M., Hughes, S. G., Graham, M. J., Crooke, R. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31009-1 · Cited by 754 · cited 4×
“The arrival of potent and specific therapies to lower Lp(a), such as antisense therapy (30,31), convey the beginning of the era of testing of the Lp(a) hypothesis.”
BackgroundMethodInfluentialSelf-citationGiugliano, R. P., Pedersen, T. R., Park, J.-G., De Ferrari, G. M., Gaciong, Z. A., Ceska, R., Toth, K., Gouni-Berthold, I., Lopez-Miranda, J., Schiele, F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32290-0 · Cited by 682
van der Valk, F. M., Bekkering, S., Kroon, J., Yeang, C., Van den Bossche, J., van Buul, J. D., Ravandi, A., Nederveen, A. J., Verberne, H. J., Scipione, C., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.020838 · Cited by 674
Self-citationStructure, function, and genetics of lipoprotein (a)
Schmidt, K., Noureen, A., Kronenberg, F., & Utermann, G. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r067314 · Cited by 638
Elevated Lipoprotein(a) and Risk of Aortic Valve Stenosis in the General Population
Kamstrup, P. R., Tybjærg-Hansen, A., & Nordestgaard, B. G. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.038 · Cited by 595
Nordestgaard, B. G., & Langsted, A. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r071233 · Cited by 575
Khera, A. V., Everett, B. M., Caulfield, M. P., Hantash, F. M., Wohlgemuth, J., Ridker, P. M., & Mora, S. (2014) · Circulation · doi:10.1161/circulationaha.113.004406 · Cited by 461 · cited 2×
“It is emphasized that this threshold is higher than the risk threshold in primary care populations of >20 to 30 mg/dl (6,13,14).”
Tsimikas, S., Viney, N. J., Hughes, S. G., Singleton, W., Graham, M. J., Baker, B. F., Burkey, J. L., Yang, Q., Marcovina, S. M., Geary, R. S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61252-1 · Cited by 460
Self-citationSeimon, T. A., Nadolski, M. J., Liao, X., Magallon, J., Nguyen, M., Feric, N. T., Koschinsky, M. L., Harkewicz, R., Witztum, J. L., Tsimikas, S., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.010 · Cited by 457
Self-citationSantos, R. D., Gidding, S. S., Hegele, R. A., Cuchel, M. A., Barter, P. J., Watts, G. F., Baum, S. J., Catapano, A. L., Chapman, M. J., Defesche, J. C., et al. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30041-9 · Cited by 419
Self-citationOxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis
Capoulade, R., Chan, K. L., Yeang, C., Mathieu, P., Bossé, Y., Dumesnil, J. G., Tam, J. W., Teo, K. K., Mahmut, A., Yang, X., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.020 · Cited by 417 · cited 6×
“Finally, in patients with or at risk for CAVD, levels may yet be even higher, at w>40 to 60 mg/dl (9).”
InfluentialSelf-citationThe role of oxidized phospholipids in atherosclerosis
Berliner, J. A., Leitinger, N., & Tsimikas, S. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800074-jlr200 · Cited by 403
Self-citationMarcovina, S. M., Albers, J. J., Gabel, B., Koschinsky, M. L., & Gaur, V. P. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.2.246 · Cited by 354
Self-citationLipoprotein (a) measurements for clinical application
Marcovina, S. M., & Albers, J. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r061648 · Cited by 338
Self-citationVirani, S. S., Brautbar, A., Davis, B. C., Nambi, V., Hoogeveen, R. C., Sharrett, A. R., Coresh, J., Mosley, T. H., Morrisett, J. D., Catellier, D. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.045120 · Cited by 324
Calcific Aortic Valve Stenosis: Methods, Models, and Mechanisms
Miller, J. D., Weiss, R. M., & Heistad, D. D. (2011) · Circulation Research · doi:10.1161/circresaha.110.234138 · Cited by 323
Arsenault, B. J., Boekholdt, S. M., Dubé, M.-P., Rhéaume, É., Wareham, N. J., Khaw, K.-T., Sandhu, M. S., & Tardif, J.-C. (2014) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.113.000400 · Cited by 315
Marcovina, S. M., Albers, J. J., Scanu, A. M., Kennedy, H., Giaculli, F., Berg, K., Couderc, R., Dati, F., Rifai, N., Sakurabayashi, I., et al. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.12.1956 · Cited by 313
Self-citationLipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
Boffa, M. B., & Koschinsky, M. L. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r060582 · Cited by 309
Self-citationMarcovina, S. M., Koschinsky, M. L., Albers, J. J., & Skarlatos, S. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.023689 · Cited by 288
Self-citationDiscrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)
Willeit, P., Kiechl, S., Kronenberg, F., Witztum, J. L., Santer, P., Mayr, M., Xu, Q., Mayr, A., Willeit, J., & Tsimikas, S. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.061 · Cited by 286
Self-citationPostmus, I., Trompet, S., Deshmukh, H. A., Barnes, M. R., Li, X., Warren, H. R., Chasman, D. I., Zhou, K., Arsenault, B. J., Donnelly, L. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6068 · Cited by 267
Davidson, M. H., Ballantyne, C. M., Jacobson, T. A., Bittner, V. A., Braun, L. T., Brown, A. S., Brown, W. V., Cromwell, W. C., Goldberg, R. B., McKenney, J. M., et al. (2011) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2011.07.005 · Cited by 262
Self-citationBouchareb, R., Mahmut, A., Nsaibia, M. J., Boulanger, M.-C., Dahou, A., Lépine, J.-L., Laflamme, M.-H., Hadji, F., Couture, C., Trahan, S., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.016757 · Cited by 260
Self-citationPhenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
Emdin, C. A., Khera, A. V., Natarajan, P., Klarin, D., Won, H.-H., Peloso, G. M., Stitziel, N. O., Nomura, A., Zekavat, S. M., Bick, A. G., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.033 · Cited by 244
Self-citationDeterminants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)
Leibundgut, G., Scipione, C., Yin, H., Schneider, M., Boffa, M. B., Green, S., Yang, X., Dennis, E., Witztum, J. L., Koschinsky, M. L., et al. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m040733 · Cited by 243
Self-citationEffects of PCSK9 inhibition with alirocumab on lipoprotein metabolism in healthy humans
Reyes-Soffer, G., Pavlyha, M., Ngai, C., Thomas, T., Holleran, S., Ramakrishnan, R., Karmally, W., Nandakumar, R., Fontanez, N., Obunike, J., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.025253 · Cited by 240
Self-citationVarvel, S., McConnell, J. P., & Tsimikas, S. (2016) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.308011 · Cited by 218
Self-citationLipoprotein(a) for Risk Assessment in Patients With Established Coronary Artery Disease
O'Donoghue, M. L., Morrow, D. A., Tsimikas, S., Sloan, S., Ren, A. F., Hoffman, E. B., Desai, N. R., Solomon, S. D., Domanski, M., Arai, K., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.09.042 · Cited by 215
Self-citationRomagnuolo, R., Scipione, C. A., Boffa, M. B., Marcovina, S. M., Seidah, N. G., & Koschinsky, M. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.611988 · Cited by 206
Self-citationTargeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions
Hoeksema, M. A., Gijbels, M. J., Van den Bossche, J., van der Velden, S., Sijm, A., Neele, A. E., Seijkens, T., Stöger, J. L., Meiler, S., Boshuizen, M. C., et al. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201404170 · Cited by 179
Yeang (2015) · doi:10.1097/mol.0000000000000171 · Cited by 152
LPA Gene, Ethnicity, and Cardiovascular Events
Lee, S. R., Prasad, A., Choi, Y. S., Xing, C., Clopton, P., Witztum, J. L., & Tsimikas, S. (2016) · Circulation · doi:10.1161/circulationaha.116.024611 · Cited by 150
Self-citationHartikainen, J. E. K., Hassinen, I., Hedman, A. E., Kivelä, A., Saraste, A., Knuuti, J. M., Husso, M., Mussalo, H., Hedman, M., Rissanen, T. T., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx352 · Cited by 147
Self-citationLangsted, A., Nordestgaard, B. G., Benn, M., Tybjærg-Hansen, A., & Kamstrup, P. R. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1206 · Cited by 136
Berg, K., Dahlén, G. H., Christophersen, B. O., Cook, T. J., KJEKSHUS, J. K., & Pedersen, T. (1997) · Clinical Genetics · doi:10.1111/j.1399-0004.1997.tb04342.x · Cited by 136
Phosphocholine as a pattern recognition ligand for CD36
Boullier, A., Friedman, P., Harkewicz, R., Hartvigsen, K., Green, S. R., Almazan, F., Dennis, E. A., Steinberg, D. H., Witztum, J. L., & Quehenberger, O. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400496-jlr200 · Cited by 122
Self-citationTsiantoulas, D., Perkmann, T., Afonyushkin, T., Mangold, A., Prohaska, T. A., Papac-Miličević, N., Millischer, V., Bartel, C., Hörkkö, S., Boulanger, C. M., et al. (2014) · Journal of Lipid Research · doi:10.1194/jlr.p054569 · Cited by 120
Self-citationVongpromek, R., Bos, S., ten Kate, G. R., Yahya, R., Verhoeven, A. J. M., de Feyter, P. J., Kronenberg, F., van Lennep, J. E. R., Sijbrands, E. J. G., & Mulder, M. T. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12335 · Cited by 115
Yeang, C., Hung, M., Byun, Y. S., Clopton, P., Yang, X., Witztum, J. L., & Tsimikas, S. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.01.005 · Cited by 114
Self-citationScavenger receptor-BI is a receptor for lipoprotein(a)
Yang, X.-P., Amar, M. J., Vaisman, B., Bocharov, A. V., Vishnyakova, T. G., Freeman, L. A., Kurlander, R. J., Patterson, A. P., Becker, L. C., & Remaley, A. T. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m038877 · Cited by 113
Self-citationPCSK9 Association With Lipoprotein(a)
Tavori, H., Christian, D., Minnier, J., Plubell, D. L., Shapiro, M. D., Yeang, C., Giunzioni, I., Croyal, M., Duell, P. B., Lambert, G. C., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.308811 · Cited by 113
Self-citationPCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo
Villard, E. F., Thedrez, A., Blankenstein, J., Croyal, M., Tran, T.-T.-T., Poirier, B., Le Bail, J.-C., Illiano, S., Nobécourt, E., Krempf, M., et al. (2016) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2016.06.006 · Cited by 113
Khan, T. Z., Hsu, L., Arai, A. E., Rhodes, S., Pottle, A., Wage, R., BANYA, W. A. S., Gatehouse, P. D., Giri, S., Collins, P. D., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx178 · Cited by 105
Jenkins, W. S. A., Vesey, A. T., Shah, A. S. V., Pawade, T., Chin, C., White, A. C., Fletcher, A. M., Cartlidge, T. R. G., Mitchell, A. J., Pringle, M. A. H., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1325 · Cited by 102
Recycling of Apolipoprotein(a) After PlgRKT-Mediated Endocytosis of Lipoprotein(a)
Sharma, M., Redpath, G. M., Williams, M. J. A., & McCormick, S. P. A. (2017) · Circulation Research · doi:10.1161/circresaha.116.310272 · Cited by 97
Schwartz, G. G., Ballantyne, C. M., Barter, P. J., Kallend, D. G., Leiter, L. A., Leitersdorf, E., McMurray, J. J. V., Nicholls, S. J., OLSSON, A. G., Shah, P. K., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.3833 · Cited by 97
Afshar, M. S., Pilote, L., Dufresne, L., Engert, J. C., & Thanassoulis, G. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.003012 · Cited by 95
Self-citationLipoprotein(a) and oxidized phospholipids in calcific aortic valve stenosis
Yeang, C., Wilkinson, M. J., & Tsimikas, S. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000300 · Cited by 93
Self-citationNsaibia, M. J., Mahmut, A., Boulanger, M., Arsenault, B. J., Bouchareb, R., Simard, S., Witztum, J. L., Clavel, M.-A. A., Pîbarot, P., Bossé, Y., et al. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12519 · Cited by 93
Self-citationThe metabolism of lipoprotein (a): an ever-evolving story
Reyes-Soffer, G., Ginsberg, H. N., & Ramakrishnan, R. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r077693 · Cited by 92
Self-citationMoriarty, P. M., Varvel, S. A., Gordts, P. L. S. M., McConnell, J. P., & Tsimikas, S. (2017) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.116.308704 · Cited by 89
Self-citationLoss of Plasma Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) After Lipoprotein Apheresis
Tavori, H., Giunzioni, I., Linton, M. F., & Fazio, S. (2013) · Circulation Research · doi:10.1161/circresaha.113.302655 · Cited by 87
Self-citationTorzewski, M., Ravandi, A., Yeang, C., Edel, A. L., Bhindi, R., Kath, S., Twardowski, L., Schmid, J. O., Yang, X., Franke, U. F. W., et al. (2017) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2017.02.004 · Cited by 87
Self-citationKamstrup, P. R., Hung, M., Witztum, J. L., Tsimikas, S., & Nordestgaard, B. G. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308761 · Cited by 85
Self-citationCairns, B. J., Coffey, S., Travis, R. C., Prendergast, B., Green, J., Engert, J. C., Lathrop, M. G., Thanassoulis, G., & Clarke, R. (2017) · Circulation · doi:10.1161/circulationaha.116.026103 · Cited by 74
Self-citationBajaj, A., Damrauer, S. M., Anderson, A. H., Xie, D., Budoff, M. J., Go, A. S., He, J., Lash, J. P., OJO, A. O., Post, W. S., et al. (2017) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309920 · Cited by 69
Self-citationGoldenberg, N. A., Bernard, T. J., Hillhouse, J., Armstrong, J., Galinkin, J. L., Knapp-Clevenger, R., Jacobson, L. J., Marcovina, S. M., & Manco‐Johnson, M. J. (2013) · Haematologica · doi:10.3324/haematol.2012.073833 · Cited by 66
Self-citationSchneider, M., Witztum, J. L., Young, S. G., Ludwig, E. H., Miller, E. R., Tsimikas, S., Curtiss, L. K., Marcovina, S. M., Taylor, J. M., Lawn, R. M., et al. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400467-jlr200 · Cited by 61
Self-citationAfshar, M. S., Kamstrup, P. R., Williams, K., Sniderman, A. D., Nordestgaard, B. G., & Thanassoulis, G. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.308271 · Cited by 51
Self-citationPuri, R., Ballantyne, C. M., Hoogeveen, R. C., Shao, M., Barter, P. J., Libby, P., Chapman, M. J., Erbel, R. M., Arsenault, B. J., Raichlen, J. S., et al. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.06.026 · Cited by 50
Arsenault, B. J., Barter, P. J., DeMicco, D. A., Bao, W., Preston, G. M., LaRosa, J. C., Grundy, S. M., DEEDWANIA, P. C., Greten, H., WENGER, N. K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114519 · Cited by 48
Yeang, C., Cotter, B. R., & Tsimikas, S. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6634-1 · Cited by 46
Self-citationEdmiston, J. B., Brooks, N. A., Tavori, H., Minnier, J., Duell, B., Purnell, J. Q., Kaufman, T. M., Wójcik, C., Vörös, S., Fazio, S., et al. (2017) · Journal of clinical lipidology · doi:10.1016/j.jacl.2017.03.001 · Cited by 43
Self-citationLipoprotein(a): Its relevance to the pediatric population
McNeal, C. J. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.07.006 · Cited by 42
Yang, X., Sethi, A. A., Yanek, L. R., Knapper, C., Nordestgaard, B. G., Tybjærg‐Hansen, A., Becker, D. M., Mathias, R. A., Remaley, A. T., & Becker, L. C. (2016) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001402 · Cited by 42
Self-citationMoriarty, P. M., & Hemphill, L. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.09.003 · Cited by 40
Self-citationVerbeek, R., Boyer, M., Boekholdt, S. M., Hovingh, G. K., Kastelein, J. J. P., Wareham, N. J., Khaw, K., & Arsenault, B. J. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307995 · Cited by 30
Yeang, C., Gordts, P. L. S. M., & Tsimikas, S. (2017) · Circulation Research · doi:10.1161/circresaha.117.310700 · Cited by 25
Self-citationRay, K. K., Ginsberg, H. N., Davidson, M. H., Louie, M. J., Bujas‐Bobanovic, M., Minini, P., Eckel, R. H., & Cannon, C. P. (2016) · Circulation · Cited by 3
Self-citation
Cited by
Padmanabhan, A., Connelly‐Smith, L., Aqui, N., Balogun, R. A., Klingel, R., Meyer, E., Pham, H. P., Schneiderman, J., Witt, V., Wu, Y., et al. (2019) · Journal of Clinical Apheresis · doi:10.1002/jca.21705 · Cited by 2,230
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Self-citationLipoprotein(a) Reduction in Persons with Cardiovascular Disease
Tsimikas, S., Karwatowska-Prokopczuk, E., Gouni-Berthold, I., Tardif, J.-C., Baum, S. J., Steinhagen-Thiessen, E., Shapiro, M. D., Stroes, E. S., Moriarty, P. M., Nordestgaard, B. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1905239 · Cited by 1,094
Self-citationReyes-Soffer, G., Ginsberg, H. N., Berglund, L., Duell, P. B., Heffron, S. P., Kamstrup, P. R., Lloyd-Jones, D. M., Marcovina, S. M., Yeang, C., Koschinsky, M. L., et al. (2022) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atv.0000000000000147 · Cited by 836
Self-citationConnelly‐Smith, L., Alquist, C. R., Aqui, N. A., Hofmann, J. C., Klingel, R., Onwuemene, O. A., Patriquin, C. J., Pham, H. P., Sanchez, A. P., Schneiderman, J., et al. (2023) · Journal of Clinical Apheresis · doi:10.1002/jca.22043 · Cited by 684
Metadata
- Authors
- Tsimikas, S., Fazio, S., Ferdinand, K. C., Ginsberg, H. N., Koschinsky, M. L., Marcovina, S. M., Moriarty, P. M., Rader, D. J., Remaley, A. T., Reyes-Soffer, G., Santos, R. D., Thanassoulis, G., Witztum, J. L., Danthi, S., Olive, M., & Liu, L.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 71
- Issue
- 2
- Pages
- 177-192
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2782889826
- Cited by
- 501
- References
- 77
- FWCI
- 48.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.